NICE undertakes world-first evaluation of antimicrobial drugs to tackle AMR HighlightsHighlights Archive

NICE undertakes world-first evaluation of antimicrobial drugs to tackle AMR

In a historic move, cefiderocol and ceftazidime–avibactam will become the first antimicrobial drugs authorised by NICE for use in the UK’s new subscription-style payment model. This forms part of a larger scheme with NHSE/I and DHSC to provide a greater incentive to research and develop much-needed antimicrobial drugs for the future. The dearth of new antimicrobials being developed and the…
Ben Kemp
April 14, 2022
AMR Innovation Mission to take place in May 2022 across three UK sites Membership NewsMembership News Archive

AMR Innovation Mission to take place in May 2022 across three UK sites

An AMR Innovation Mission is to take place during a week in May 2022, with 25 companies from the EU, USA and the rest of the world due to visit three AMR hotspots in the UK. Those involved will be meeting with established companies, and taking part in 1:1 partnering sessions. The overall aim of the inward AMR Innovation Mission…
Ben Kemp
February 25, 2022